Popularity #3,171Dividend on the way · $0.16
Chiron Real Estate (XRN)
Acquires and leases medical office buildings and surgical hospitals to regional health systems.
$35.84
vs last close−0.70 (−1.92%)
In millions of USD, except per-share figures
| In millions | Q4 FY20Dec 2020 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25 | 33 | 35 | 34 | 34 | 35 | 38 | 41 | 41 | 38 | 38 | 40 |
| Cost of revenue | 0 | 6 | 7 | 7 | 7 | 7 | 35 | 39 | 38 | 38 | 39 | 41 |
| Gross profit | 25 | 27 | 28 | 27 | 27 | 28 | 3 | 2 | 2 | 0 | −1 | −1 |
| 10 | 18 | 19 | 19 | 18 | 21 | −10 | −9 | −10 | −9 | −10 | −10 | |
| 10 | 4 | 4 | 5 | 4 | 8 | 12 | 15 | 14 | 5 | 5 | 5 | |
| Selling & marketing | 5 | 0 | 0 | 0 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | 0 |
| General & administrative | 4 | 4 | 4 | 5 | 4 | 8 | 4 | 5 | 5 | 5 | 5 | 5 |
| Other expenses | 0 | 14 | 14 | 14 | 14 | 14 | −22 | −24 | −24 | −15 | −15 | −15 |
| Operating income | 15 | 8 | 9 | 8 | 9 | 6 | 13 | 12 | 12 | 9 | 9 | 9 |
| −12 | −8 | −7 | −10 | −5 | −3 | −9 | −11 | −18 | −16 | −7 | 63 | |
| Interest expense | 5 | 7 | 7 | 7 | 7 | 8 | 10 | 11 | 12 | 8 | 7 | 9 |
| Other non-operating income | 7 | 1 | 0 | 3 | −2 | −4 | −1 | 0 | 6 | 7 | 0 | −72 |
| Income before tax | 3 | 1 | 2 | −2 | 3 | 3 | 4 | 1 | −5 | −6 | 2 | 72 |
| Net income from continuing operations | 3 | 1 | 2 | −2 | 3 | 3 | 4 | 1 | −5 | −6 | 2 | 72 |
| Net income | 3 | 1 | 2 | −2 | 3 | 3 | 4 | 1 | −5 | −6 | 2 | 66 |
| EPS, basic | $1.30 | $0.24 | $0.06 | −$1.74 | $0.68 | $0.52 | $0.16 | $0.05 | −$0.45 | −$0.55 | $0.13 | $4.78 |
| EPS, diluted | $1.30 | $0.24 | $0.06 | −$1.74 | $0.68 | $0.52 | $0.16 | $0.05 | −$0.45 | −$0.55 | $0.13 | $4.78 |
| Weighted average shares, basic | 2 | 3 | 3 | 3 | 3 | 3 | 13 | 13 | 13 | 13 | 13 | 13 |
| Weighted average shares, diluted | 2 | 3 | 3 | 3 | 3 | 3 | 13 | 13 | 13 | 13 | 13 | 13 |
| EBITDA | 17 | 22 | 23 | 19 | 24 | 24 | 28 | 27 | 21 | 17 | 24 | 96 |
| Depreciation & amortization | 9 | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 15 | 15 |
| EBIT | 8 | 8 | 9 | 5 | 11 | 11 | 14 | 12 | 6 | 2 | 9 | 81 |